ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,814.00
      -0.16%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.625
      -0.85%
      Bitcoin
      62,550.84
      -3.53%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mesoblast Limited (MESO)

      7. Mesoblast Limited (MESO) News

      MESO

      Mesoblast (MESO)

      Mesoblast Limited
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MESO
      DateTimeSourceHeadlineSymbolCompany
      05/06/20196:09AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      04/23/20196:10AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      04/16/20196:00AMGlobeNewswire Inc.FDA Agrees to Rolling Review of Mesoblast’s Biologics License Application for Its Cell Therapy in Children With Steroid-Ref...NASDAQ:MESOMesoblast Limited
      04/11/20196:07AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      04/05/20196:00AMGlobeNewswire Inc.Mesoblast to Present at Upcoming Global Life Sciences Conference in LondonNASDAQ:MESOMesoblast Limited
      03/28/20196:13AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      03/26/201911:00AMGlobeNewswire Inc.Memorandum of Understanding for Confirmatory Trial to Support Marketing Approval of Revascor for Reduction of Gastrointestina...NASDAQ:MESOMesoblast Limited
      03/26/20196:09AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      03/25/20196:00AMGlobeNewswire Inc.Mesoblast Licensee Files for Marketing Approval to Treat Epidermolysis BullosaNASDAQ:MESOMesoblast Limited
      03/22/20194:36PMGlobeNewswire Inc.U.S. Healthcare Leader Joseph R. Swedish Appointed Mesoblast ChairmanNASDAQ:MESOMesoblast Limited
      03/14/20195:25PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      03/13/20196:00AMGlobeNewswire Inc.Mesoblast Features at Upcoming U.S. Investor ConferencesNASDAQ:MESOMesoblast Limited
      02/22/20196:12AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      02/22/20196:10AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      02/22/20196:10AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      02/20/20195:16PMGlobeNewswire Inc.Mesoblast Reports Financial Results and Operational Highlights for the First Half Ended December 31, 2018NASDAQ:MESOMesoblast Limited
      02/19/20196:00AMGlobeNewswire Inc.Final Patient Dosed in Mesoblast Phase 3 Trial of Revascor Cell Therapy for Advanced Heart FailureNASDAQ:MESOMesoblast Limited
      02/14/20196:37AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MESOMesoblast Limited
      02/14/20196:30AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MESOMesoblast Limited
      02/13/20195:06PMGlobeNewswire Inc.Mesoblast Financial Results Webcast for Half Year, Q2 Ended December 31, 2018NASDAQ:MESOMesoblast Limited
      02/05/201912:41PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MESOMesoblast Limited
      02/05/20196:11AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      01/18/20194:52PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      01/14/201910:46AMGlobeNewswire Inc.Hercules Capital Provides US$15M From Existing Facility for Mesoblast to Accelerate Product Commercialization ProgramsNASDAQ:MESOMesoblast Limited
      01/14/20196:12AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      01/07/20197:44PMGlobeNewswire Inc.Mesoblast Highlights 2019 Key Priorities for its Leading Cellular Medicines Pipeline at Biotech Showcase in San FranciscoNASDAQ:MESOMesoblast Limited
      01/07/20196:00AMGlobeNewswire Inc.Phase 3 Trial of Mesoblast’s Cell Therapy in Chronic Heart Failure Completes RecruitmentNASDAQ:MESOMesoblast Limited
      01/04/20196:06AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      12/28/20186:00AMGlobeNewswire Inc.Mesoblast Corporate ReviewNASDAQ:MESOMesoblast Limited
      12/24/20186:30AMGlobeNewswire Inc.Mesoblast to Present at 2019 Biotech Showcase in San FranciscoNASDAQ:MESOMesoblast Limited
       Showing the most relevant articles for your search:NASDAQ:MESO

      Your Recent History

      LSE
      0RIA
      Diagnostic Medical Systems
      Delayed Upgrade Clock